课题基金 / 基金详情

A PRELIMINARY STUDY TO EVALUATE CYSTEAMINE THERAPY IN HUMAN SUBJECTS WITH NASH

A PRELIMINARY STUDY TO EVALUATE CYSTEAMINE THERAPY IN HUMAN SUBJECTS WITH NASH
评估半胱胺治疗纳什人类受试者的初步研究
批准号：
8166857
负责人：
JOEL Edward LAVINE
金额：
$1.83万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-12-01 至 2010-06-30
来源：
https://reporter.nih.gov/project-details/8166857
关键词：
Biological MarkersComputer Retrieval of Information on Scientific Projects DatabaseCysteamineFundingGrantInstitutionResearchResearch PersonnelResourcesSourceSteatohepatitisUnited States National Institutes of Healthhuman subject

项目摘要

项目成果

JOEL Edward LAVINE的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 目的：确定半胱胺是否能有效降低或逆转人类脂肪性肝炎的生物标志物。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To determine whether cysteamine will effectively reduce or reverse the biologic markers of steatohepatitis in human subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
XENOBIOTIC BIOTRANSFORMATION IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE
CLINICAL TRIAL: TONIC - TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN
CLINICAL TRIAL: PIOGLITAZONE VS VITAMIN E VS PLACEBO FOR NONALCOHOLIC STEATOHEPA
CLINICAL TRIAL: NON-ALCOHOLIC STEATOHEPATITIS CLINICAL RESEARCH NETWORK